2011 Press Releases
July 26, 2011
arGEN-X Announces Non-exclusive License with BioWa for Potelligent Technology
June 2, 2011
ICT and BioWa Announce License for R&D of Therapeutic Antibodies in Cancer
June 1, 2011
Caerus Discovery, LLC – A New Biotechnology Company is Announced
April 6, 2011
Oxford BioTherapeutics Licenses BioWa’s POTELLIGENT Technology
February 8, 2011
Kalobios Selects Potelligent CHOK1SV Cell Line for the Research-Development and Manufacture of Humaneered Antibodies